National Institutes Of Health

Curious About Cannabis Edibles? Fed Health Agency Funds Project To Study Use Among Young Adults
Robert Kennedy Jr: Trump Wants Him To Help Pick CDC, FDA, and NIH Leaders — 'Unravel The Capture Of Agencies By Corrupt Influence'
Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds
Robert Kennedy Jr: Trump Wants Him To Help Pick CDC, FDA, and NIH Leaders — 'Unravel The Capture Of Agencies By Corrupt Influence'
Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds
Federal Money To Support Research On Psychedelics As Alternative To Pills For Chronic Pain Among The Elderly
Cannabis vs. Alcohol: Which Is Preferable For Better Sleep Among Those Suffering From Anxiety?

National Institutes Of Health Recent News

E-Cigarette Use Poses Severe Respiratory Threat To Young People Within 30 Days: Study
New Study: Morphine Use Among Cancer Patients Linked To Bone Loss And Pain, Is Medical Marijuana An Option?
University of Arizona Health Sciences researchers have found that chronic morphine use may contribute to bone loss and heightened pain, according to a study published in PAIN.
Bipartisan Letter Calls For Including Active Service Members In Psychedelic-Assisted Therapy Research
A bipartisan legislative effort led by Rep. Dan Crenshaw aims to urge the participation of active-duty servicemembers in the National Institutes of Health (NIH)-funded research with psychedelics.
NIDA Director Dr. Nora Volkow Calls For 'Urgent' Research Into Risks Of Regular Cannabis Use, Citing Effects On Brain Development
This week, an annual drug use survey Monitoring the Future (MTF), conducted by scientists at the University of Michigan’s Institute for Social Research, Ann Arbor 
House Passes Revised Cannabis Research Bill, Senate Expected To 'Move Quickly'
The U.S. House of Representatives passed a revised version of the bipartisan marijuana research bill that would substantially expand scientific research on Tuesday, just days following its introduction in Congress.
Government-Funded Smoking Cessation Trial Uses Mydecine's New Psilocybin-Derived MYCO-001, Recently FDA-Approved
Biotech company Mydecine Innovations Group (OTC: MYCOF) received FDA approval for their novel proprietary MYCO-001. This is the first clearance of the company’s drug product. 
Cannabis In Cancer Treatment: Feds To Fund New Research In These Areas Of Interest
In cancer patients, cannabinoids have primarily been used as a part of palliative care to help alleviate pain, reduce inflammation, relieve nausea and stimulate appetite.
Historic: Federal Agency Awards Grant For Psychedelics Research, First Time In 50 years
The National Institutes of Health awarded a nearly $4 million grant meant to fund research on psilocybin, the active ingredient in “magic mushrooms,” to researchers at Johns Hopkins University.
Emergent BioSolutions' COVID-19 Plasma Candidate To Be Tested As Outpatient Treatment
Trevena's TRV027 To Be Tested In NIH-Funded COVID-19 Trial
NIH Starts Study On Allergic Reactions Risk To Pfizer/BioNTech, Moderna COVID-19 Vaccines
No Conclusive Evidence On Convalescent Plasma Use Against COVID-19, NIH Says After FDA Emergency Use Approval
The National Institutes Of Health said Tuesday that after reviewing available evidence from published and unpublished data on convalescent plasma therapy for COVID-19, it had concluded there is no case for recommending or advising against such a treatment.
Gilead's Remdesivir-Like Compound To Be Studied By NIH For Efficacy Against COVID-19
The National Institutes Of Health is set to investigate a Gilead Sciences, Inc (NASDAQ: GILD) compound, similar to remdesivir, which could be effective against COVID-19, Stat reported Monday.
Pain Therapeutics Granted $3.5M For Alzheimer's Study, CEO Comments On Micro-Cap Volatility
What Would A $5.8 Billion NIH Cut Look Like? Devastation.
U.S. Researchers Begin Clinical Trial Of Zika Vaccine, But Funding To Run Out By August's End
Medivation Drops 12% After Congress Asks To Examine Xtandi Drug Price
Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved